Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis

Clinical trial NCT01670565 · COMPLETED

Trial details

NCT number: NCT01670565
Sponsor: Hospital for Special Surgery, New York
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Sclerosis

Start date: 2012-08-01
Primary completion: 2015-11-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.